Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Hong Kong Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20071
20081
20091
20101
20111
20122
20131
20151
20182
20191
20213
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novartis Pharmaceuticals3
Amgen2
NRG Oncology2
Pfizer2
Bayer1
Cogent Biosciences, Inc.1
Egetis Therapeutics1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis22
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Neoplasms5
Carcinoma, Renal Cell4
Colorectal Neoplasms4
Brain Neoplasms2
Carcinoma2
Colonic Neoplasms2
Lung Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.